Development and evaluation of a new IgM/IgG rapid diagnostic test for SARS-CoV-2
View ORCID ProfileP.J. Ducrest
doi: https://doi.org/10.1101/2020.10.09.20209866
P.J. Ducrest
1GaDia SA, Route de l’ile au bois 1A, 1870 Monthey, Switzerland
Article usage
Posted October 13, 2020.
Development and evaluation of a new IgM/IgG rapid diagnostic test for SARS-CoV-2
P.J. Ducrest
medRxiv 2020.10.09.20209866; doi: https://doi.org/10.1101/2020.10.09.20209866
Subject Area
Subject Areas
- Addiction Medicine (324)
- Allergy and Immunology (632)
- Anesthesia (168)
- Cardiovascular Medicine (2400)
- Dermatology (207)
- Emergency Medicine (381)
- Epidemiology (11797)
- Forensic Medicine (10)
- Gastroenterology (705)
- Genetic and Genomic Medicine (3769)
- Geriatric Medicine (350)
- Health Economics (637)
- Health Informatics (2408)
- Health Policy (940)
- Hematology (342)
- HIV/AIDS (787)
- Medical Education (369)
- Medical Ethics (105)
- Nephrology (401)
- Neurology (3524)
- Nursing (199)
- Nutrition (529)
- Oncology (1835)
- Ophthalmology (539)
- Orthopedics (221)
- Otolaryngology (287)
- Pain Medicine (234)
- Palliative Medicine (66)
- Pathology (447)
- Pediatrics (1037)
- Primary Care Research (424)
- Public and Global Health (6184)
- Radiology and Imaging (1291)
- Respiratory Medicine (832)
- Rheumatology (380)
- Sports Medicine (324)
- Surgery (406)
- Toxicology (50)
- Transplantation (172)
- Urology (147)